News
Once-daily drug effective in COPD, researchers say
Medpage Today
VANCOUVER, BC—A novel once-daily beta-2 agonist appears as effective against chronic obstructive pulmonary disease (COPD) as once-daily anticholinergic treatment, researchers found.
Indacaterol matched tiotropium (Spiriva) for improved lung function, Leonard Jay Dunn, MD, of Clinical Research of West Florida in Clearwater, FL, and colleagues reported at the CHEST meeting.
CHEST is the annual meeting of the American College of Chest Physicians, now being held in Vancouver.
The experimental inhaled drug also appeared to hold some advantages for shortness of breath and for the need for rescue albuterol in the industry-sponsored trial. Dunn said once-a-day treatment will make it easier for patients to take the correct dose regularly.
